SHOURJO CHAKRAVORTY
Allopathic & Osteopathic Physicians|Internal Medicine MEDIA, PA NPI 1770108417
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine PA Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$172.60
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $172.60 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $172.60 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.19 | 4 |
| GlaxoSmithKline, LLC. | $48.54 | 2 |
| Genentech USA, Inc. | $27.92 | 1 |
| Electromed, Inc. | $14.95 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $172.60 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1116075541 | GlaxoSmithKline, LLC. | $24.18 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116108323 | GlaxoSmithKline, LLC. | $24.36 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118146104 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.87 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118146106 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.93 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118146108 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22.23 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118146110 | Boehringer Ingelheim Pharmaceuticals, Inc. | $29.16 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133113124 | Genentech USA, Inc. | $27.92 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137883258 | Electromed, Inc. | $14.95 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.